Dimebon Inhibits Calcium-Induced Swelling of Rat Brain Mitochondria But Does Not Alter Calcium Retention or Cytochrome C Release

The Puzzling Rise and Fall of a Dark-Horse Alzheimer's Drug

(2010) G. Miller   SCIENCE

Omega-3 fatty acids: potential role in the management of early Alzheimer’s disease

(2010) Greg Jicha   Clinical Interventions in Aging

Evaluation of putative inhibitors of mitochondrial permeability transition for brain disorders — Specificity vs. toxicity

(2009) Saori Morota et al.   EXPERIMENTAL NEUROLOGY

Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease

(2009) P. Hemachandra Reddy   EXPERIMENTAL NEUROLOGY

Organoselenium (Sel-Plex diet) decreases amyloid burden and RNA and DNA oxidative damage in APP/PS1 mice

(2009) Mark A. Lovell et al.   FREE RADICAL BIOLOGY AND MEDICINE

Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age

(2008) Hafiz Mohmmad Abdul et al.   FREE RADICAL BIOLOGY AND MEDICINE

Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models

(2008) Joshua A. Sonnen et al.   FREE RADICAL BIOLOGY AND MEDICINE

Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study

(2008) Rachelle S Doody et al.   LANCET

Evaluation of Dimebon in cellular model of Huntington's disease

(2008) Jun Wu et al.   Molecular Neurodegeneration

Evidence that γ-secretase mediates oxidative stress-induced β-secretase expression in Alzheimer's disease

(2008) Dong-Gyu Jo et al.   NEUROBIOLOGY OF AGING

Characteristics of the Calcium-Triggered Mitochondrial Permeability Transition in Nonsynaptic Brain Mitochondria

(2003) Tibor Kristián et al.   JOURNAL OF NEUROCHEMISTRY